We are live on
!
Find out more
WA
WESPAC Advisors Portfolio holdings
AUM
$183M
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+6.06%
1 Year Est. Return
+29.81%
3 Year Est. Return
+84.48%
5 Year Est. Return
+101.16%
10 Year Est. Return
+413.59%
AUM
$87.8M
AUM Growth
-$27.7M
(-24%)
Cap. Flow
-$32.5M
Cap. Flow
% of AUM
-37.04%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
141
New
7
Increased
5
Reduced
94
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$1.84M |
| 2 |
First Trust Energy AlphaDEX Fund
FXN
|
+$1.82M |
| 3 |
Freeport-McMoran
FCX
|
+$1.35M |
| 4 |
Williams Companies
WMB
|
+$1.28M |
| 5 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$1.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$2.57M |
| 2 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$1.88M |
| 3 |
Trinity Industries
TRN
|
+$1.05M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$1.03M |
| 5 |
Gilead Sciences
GILD
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 13.57% |
| 2 | Energy | 9.12% |
| 3 | Financials | 9.06% |
| 4 | Consumer Staples | 7.02% |
| 5 | Materials | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Apple
AAPL
$4.97T
| $672K | 0.77% |
28,920
-13,752
| -32% | -$293K |
|
|
RDS.B
52
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $672K | 0.77% |
7,720
-4,572
| -37% | -$380K |
|
53
iShares US Healthcare Providers ETF
IHF
$1.22B
| $661K | 0.75% |
32,125
-14,160
| -31% | -$279K |
|
54
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $654K | 0.75% |
21,230
-2,230
| -10% | -$68.6K |
|
55
Union Pacific
UNP
$174B
| $650K | 0.74% |
6,516
+1,390
| +27% | +$135K |
|
56
Comcast
CMCSA
$87.3B
| $647K | 0.74% |
24,090
-4,110
| -15% | -$106K |
|
57
iShares US Pharmaceuticals ETF
IHE
$1.49B
| $640K | 0.73% |
14,220
-7,047
| -33% | -$303K |
|
|
ARI
58
Apollo Commercial Real Estate
ARI
$864M
| $622K | 0.71% |
37,690
-19,522
| -34% | -$326K |
|
59
Enterprise Products Partners
EPD
$83.7B
| $611K | 0.7% |
15,612
-14,452
| -48% | -$533K |
|
|
VGR
60
DELISTED
Vector Group Ltd.
VGR
| $607K | 0.69% |
55,471
-27,601
| -33% | -$302K |
|
61
RTX Corp
RTX
$290B
| $591K | 0.67% |
8,134
-899
| -10% | -$66.2K |
|
62
CVS Health
CVS
$135B
| $579K | 0.66% |
7,685
-1,392
| -15% | -$105K |
|
63
Amgen
AMGN
$209B
| $578K | 0.66% |
4,882
-961
| -16% | -$111K |
|
|
ETP
64
DELISTED
Energy Transfer Partners L.p.
ETP
| $536K | 0.61% |
9,249
-8,100
| -47% | -$454K |
|
65
AT&T
T
$164B
| $527K | 0.6% |
19,725
-14,044
| -42% | -$376K |
|
66
AstraZeneca
AZN
$269B
| $526K | 0.6% |
7,081
-4,910
| -41% | -$355K |
|
67
Silicon Motion
SIMO
$7.11B
| $523K | 0.6% |
25,591
-15,195
| -37% | -$259K |
|
|
LINE
68
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
| $514K | 0.59% |
16,411
-13,183
| -45% | -$387K |
|
69
ExxonMobil
XOM
$650B
| $507K | 0.58% |
5,036
-4,161
| -45% | -$420K |
|
70
ConocoPhillips
COP
$144B
| $504K | 0.57% |
5,877
-6,849
| -54% | -$534K |
|
|
PBCT
71
DELISTED
People's United Financial Inc
PBCT
| $488K | 0.56% |
32,165
-7,586
| -19% | -$111K |
|
72
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
| $484K | 0.55% |
5,562
-380
| -6% | -$31.9K |
|
73
Bank of America
BAC
$429B
| $475K | 0.54% |
30,886
-2,335
| -7% | -$36.3K |
|
|
RTN
74
DELISTED
Raytheon Company
RTN
| $471K | 0.54% |
5,107
-384
| -7% | -$37.2K |
|
75
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.41B
| $448K | 0.51% |
8,879
+3,362
| +61% | +$164K |
|
Similar funds
MAM
ACG
CF
QC
SPI
RMC
MCM
BWA
WESPAC Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, WESPAC Advisors held 141 positions worth $87.8M, down 24% from $115M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
WESPAC Advisors withdrew a net $32.5M in Q2 2014, closing 31 positions and reducing 94 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, WESPAC Advisors opened a new position in First Trust Consumer Discretionary AlphaDEX Fund worth $1.91M.
- WESPAC Advisors's largest Q2 2014 buy was First Trust Consumer Discretionary AlphaDEX Fund: 57,553 shares worth $1.91M.
- WESPAC Advisors added most to Williams Companies in Q2 2014, an estimated $1.28M increase.
- WESPAC Advisors's biggest Q2 2014 reduction was Trinity Industries, cutting an estimated $1.05M.
- WESPAC Advisors fully exited Thermo Fisher Scientific in Q2 2014, selling an estimated $2.57M.
- WESPAC Advisors's ten largest holdings make up 22% of its $87.8M portfolio in Q2 2014.
- WESPAC Advisors opened 7 new positions and closed 31 in Q2 2014.
- WESPAC Advisors's portfolio value fell 24% quarter-over-quarter to $87.8M.
Based on WESPAC Advisors's 13F filing for Q2 2014, filed 31 Jul 2014.